isomethyleugenol has been researched along with ranitidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasco, M; del Villar, E; Gaule, C; Vega, P | 1 |
| Agúndez, JA; Albet, C; Benítez, J; Carrillo, JA; Herrero, E; Márquez, M; Martínez, C; Ortiz, JA | 1 |
1 trial(s) available for isomethyleugenol and ranitidine
| Article | Year |
|---|---|
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
Topics: Adult; Anti-Anxiety Agents; Antitussive Agents; Aryl Hydrocarbon Hydroxylases; Benzenesulfonates; Caffeine; Central Nervous System Stimulants; Cimetidine; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Double-Blind Method; Histamine H2 Antagonists; Humans; In Vitro Techniques; Male; Methylation; Microsomes, Liver; Midazolam; Oxidoreductases, N-Demethylating; Psychomotor Performance; Ranitidine; Thiazoles | 1999 |
1 other study(ies) available for isomethyleugenol and ranitidine
| Article | Year |
|---|---|
[H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
Topics: Administration, Oral; Aminopyrine; Animals; Biotransformation; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Enzyme Induction; Famotidine; Hemeproteins; Histamine H2 Antagonists; Male; Methylation; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Ranitidine; Rats; Rats, Wistar; Superoxides | 1992 |